Svr12 0938 published presentations and documents on DocSlides.
0938 1230 APPLICATION FOR ENROLLMENT IN MEDICARE ...
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...
ELECTRON (Overview): 6 parts, 22 arms. Phase . 2....
TURQUOISE II: Genotype 1b SVR12 Based on Prior Tre...
TURQUOISE-II. Phase 3. . Treatment. Naïve and ...
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...
400/100 mg . qd. N = 500. N = 100. W12. Placebo. ...
With Or Without Ribavirin Is Safe and Efficacious...
1. Le 29-01-2015. Les anticorps neutralisants ant...
Genotype . 1 . (. Viral . Relapsers. ). PROMISE ....
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...
versus . Telaprevir. . with PR in GT1 . ATTAIN ...
. + Sofosbuvir +/- Ribavirin in Genotype 1. COS...
HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...
3. Rd. International . HIV/Hepatitis . Coinfecti...
400/100/100 mg QD. N = 501. N = 440. W8. SOF/VEL ...
Randomisation. Open-label. W8. * Liver biopsy or ...
With Or Without Ribavirin Is Safe and Efficacious...
VALENCE Trial. Phase . 3. Treatment. Naïve and ...
Open-label. Chronic HCV infection. Genotype 1 . F...
Open label. ≥ . 18 years. HCV genotype 4, 5 or...
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...
in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
Randomisation. 1 : 1. 18-70 years. HCV genotype 1...
18 years. BMI ≥ 18 kg/m. 2. HCV genotype 2, 4, ...
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
Interim Analysis of a French Multicenter Compassi...
C-EDGE Co-Infected: Phase 3 Study of Grazoprevi...
. with Advanced Liver Disease. ALLY-3+ Study. Phas...
HCV . GT 1,4, or 6 in PWID* on Opiate Agonist Ther...
. Plus . Sofosbuvir. With or Without Ribavirin . ...
SOLAR-2. Source: . Manns. M, et al. Lancet Infect...
Copyright © 2024 DocSlides. All Rights Reserved